HB
EW icon

Horizon Bancorp’s Edwards Lifesciences EW Stock Holding History

Horizon Bancorp’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-130
Closed -$11K – 236
2023
Q1 		$11K Sell
130
-69
-35% -$5.42K 0.01% 134
2022
Q4 		$15K Buy
+199
New +$15.3K 0.01% 163
2020
Q3 		$191K Sell
2,389
-64
-3% -$4.99K 0.27% 107
2020
Q2 		$170K Sell
2,453
-16
-0.6% -$1.14K 0.18% 118
2020
Q1 		$155K Sell
2,469
-648
-21% -$46.7K 0.24% 110
2019
Q4 		$242K Buy
+3,117
New +$243K 0.23% 134

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Horizon Bancorp's EW Position: Q2 2023 in Review

Horizon Bancorp sold out of Edwards Lifesciences (EW) in Q2 2023, closing a stake of 130 shares — an estimated $11K sold.

Horizon Bancorp first reported a position in EW in Q4 2019 and held it in 6 quarters. The position peaked at $242K in Q4 2019. 1,278 funds tracked by Wall St. Rank hold EW as of Q2 2023.

  • Horizon Bancorp reported no remaining Edwards Lifesciences position as of Q2 2023 after selling out during the quarter.
  • Horizon Bancorp sold 130 Edwards Lifesciences shares in Q2 2023, an estimated $11K.
  • Horizon Bancorp first reported a position in Edwards Lifesciences in Q4 2019 and held it in 6 quarters.
  • Horizon Bancorp's Edwards Lifesciences position peaked at $242K in Q4 2019.
  • 1,278 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on Horizon Bancorp's 13F filing for Q2 2023, filed 3 Aug 2023.